New Software Integrates with Leading Cryo-EM Solutions to Speed Data Collection for $1.6 Trillion Pharma Industry Research CLEVELAND, Ohio, July 30, 2024 – Health Technology Innovations (HTI), a leader in AI automation in pharma research, announced the delivery of its CryoFAST AI Data Automation Software today at the Microscopy and Microanalysis conference. CryoFAST has been […]
Collaboration Will Provide Protein Production and Analysis for HTI’s Cryo-EM Services CLEVELAND, Ohio, July 29, 2024 – Health Technology Innovations (HTI), a leader in AI automation in pharma research, and KanPro Research, Inc., a protein production contract research organization (CRO) headquartered in the Kansas University Innovation Park, announced a deep collaboration today to integrate KanPro […]
PORTLAND, Oregon, Feburary 1, 2024 Health Technology Innovations, Inc. (HTI) is excited to announce that Dr. Leah Frye, is joining HTI Advisory Board as Senior Advisor. Dr. Frye has 40 years of experience in drug discovery with an emphasis on medicinal and computational chemistry. Currently, she is the sole owner of LLFrye Consulting. In […]
PORTLAND, Oregon, May 1, 2023 — Health Technology Innovations, Inc. (HTI) is excited to announce that Dr. Santi Adavani is joining HTI Advisory Board as Senior Advisor. Dr. Adavani brings extensive experience in AI/ML and software product development to HTI. Dr. Adavani is an accomplished technology leader with a demonstrated history of driving innovation and delivering impactful […]
PORTLAND, Oregon, March 15, 2023 — Health Technology Innovations, Inc. (HTI) is excited to announce that Dr. Gabriella Kiss is joining HTI as a Senior Advisor. Dr. Kiss brings extensive experience in life science and Business Development to HTI. She is currently the Director of Global Strategic Account at Refeyn, Inc., where she is overseeing business with large pharma and […]
The M&M (Microscopy & Microanalysis) and ACA (American Crystallographic Association) 2022 events are being held in Portland, Oregon from July 29th – August 4th. HTI is based in Portland and will be attending both events, giving presentations on its AI-based cryo-EM software (CryoDiscovery™), discussing its cryo-EM structure determination services., and meeting with partners and customers. […]
FOR IMMEDIATE RELEASE PORTLAND, Oregon, March 21, 2022 Health Technology Innovations, Inc. (HTI) is excited to announce that Dr. Doug Kawahara is joining HTI as Senior Advisor for AI/ML in Drug Discovery. Dr. Kawahara brings extensive experience in drug discovery and development to HTI. He is currently President & CEO of Elex Biotech (Portland, OR), […]
The NSF has recognized HTI’s progress applying AI/ML to cryo-EM image processing with a $1M SBIR Phase II grant award for CryoDiscovery(™), a cryo-EM automation and intelligence platform for drug discovery. A Phase I award was earlier used to successfully build and test a platform prototype, while the Phase II award will play a key […]
FOR IMMEDIATE RELEASE PORTLAND, Oregon, February 24, 2021 Health Technology Innovations, Inc. (HTI) today announced that Dr. Craig Yoshioka is joining HTI as Senior Advisor for Cryo-EM. Dr. Yoshioka is Co-Director of the Pacific Northwest Cryo-EM Center (PNCC), one of three national cryo-EM centers funded by the National Institutes of Health (NIH) and jointly operated […]
PORTLAND, Oregon, January 19, 2021 — Health Technology Innovations, Inc. (HTI) today announced that Dr. Jeff King is joining HTI as a Senior Advisor. Dr. King is CEO and co-founder of Virogenomics BioDevelopment, Inc. (VBD), a biotechnology research and development company that collaborates extensively with scientists at Oregon Health and Science University (OHSU) who are […]